Simplex Trading
ORMP icon

Simplex Trading’s Oramed Pharmaceuticals ORMP Stock Holding History

Simplex Trading’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340 Hold
100
– – ﹤0.01% 8780
2025
Q4 		$285 Sell
100
-1,800
-95% -$4.64K ﹤0.01% 8227
2025
Q3 		$5K Hold
1,900
– – ﹤0.01% 8334
2025
Q2 		$4K Buy
1,900
+1,100
+138% +$2.43K ﹤0.01% 7877
2025
Q1 		$1K Buy
+800
New +$1.85K ﹤0.01% 8272
2024
Q3 		– Sell
-5,300
Closed -$13K – 9271
2024
Q2 		$13K Buy
5,300
+100
+2% +$238 ﹤0.01% 7255
2024
Q1 		$15K Sell
5,200
-7,800
-60% -$21.8K ﹤0.01% 7332
2023
Q4 		$30K Buy
13,000
+800
+7% +$1.71K ﹤0.01% 6562
2023
Q3 		$31K Sell
12,200
-1,800
-13% -$5.67K ﹤0.01% 6230
2023
Q2 		$50K Buy
14,000
+3,900
+39% +$12.5K ﹤0.01% 5845
2023
Q1 		$22K Sell
10,100
-10,700
-51% -$34K ﹤0.01% 6822
2022
Q4 		$250K Sell
20,800
-9,300
-31% -$72.3K ﹤0.01% 3948
2022
Q3 		$195K Buy
30,100
+13,500
+81% +$109K ﹤0.01% 4643
2022
Q2 		$76K Sell
16,600
-4,800
-22% -$25.6K ﹤0.01% 5946
2022
Q1 		$185K Buy
21,400
+6,000
+39% +$61.5K ﹤0.01% 5271
2021
Q4 		$219K Buy
15,400
+2,900
+23% +$60.6K ﹤0.01% 5062
2021
Q3 		$166K Sell
12,500
-400
-3% -$6.81K ﹤0.01% 5893
2021
Q2 		$172K Buy
+12,900
New +$148K ﹤0.01% 5932
2021
Q1 		– Sell
-464
Closed -$196K – 9702
2020
Q4 		$196K Buy
464
+440
+1,833% +$1.43K ﹤0.01% 4632
2020
Q3 		$6K Sell
24
-336
-93% -$1.17K ﹤0.01% 7037
2020
Q2 		$127K Sell
360
-67
-16% -$225 ﹤0.01% 4541
2020
Q1 		$129K Buy
427
+13
+3% +$57 ﹤0.01% 4096
2019
Q4 		$213K Buy
+414
New +$1.55K ﹤0.01% 3685
2019
Q3 		– Sell
-37
Closed -$13K – 7700
2019
Q2 		$13K Buy
+37
New +$131 ﹤0.01% 5951
2019
Q1 		– Sell
-10
Closed -$3K – 7651
2018
Q4 		$3K Hold
10
– – ﹤0.01% 6442
2018
Q3 		$4K Sell
10
-14
-58% -$73 ﹤0.01% 6854
2018
Q2 		$17K Buy
24
+9
+60% +$65 ﹤0.01% 5990
2018
Q1 		$1K Sell
15
-30
-67% -$232 ﹤0.01% 5725
2017
Q4 		$4K Buy
45
+1
+2% +$10 ﹤0.01% 4721
2017
Q3 		$9K Buy
44
+15
+52% +$129 ﹤0.01% 3877
2017
Q2 		$4K Buy
29
+19
+190% +$143 ﹤0.01% 4796
2017
Q1 		$3K Buy
+10
New +$62 ﹤0.01% 5039
2016
Q4 		– Sell
-58
Closed -$1K – 6331
2016
Q3 		$1K Hold
58
– – ﹤0.01% 5394
2016
Q2 		$4K Buy
+58
New +$494 ﹤0.01% 4457
2016
Q1 		– Sell
-12
Closed -$2K – 6051
2015
Q4 		$2K Buy
+12
New +$91 ﹤0.01% 4543
2015
Q2 		– Sell
-19
Closed -$1K – 5672
2015
Q1 		$1K Buy
+19
New +$92 ﹤0.01% 4539

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's ORMP Position: Q1 2026 in Review

Simplex Trading reduced its Oramed Pharmaceuticals (ORMP) stake by 67% in Q1 2026, selling an estimated $2.62K and leaving 374 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #8517.

Simplex Trading first reported a position in ORMP in Q4 2014 and has held it in 21 quarters since. The position peaked at $462K in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Simplex Trading held 374 shares of Oramed Pharmaceuticals worth $1.27K as of Q1 2026.
  • Simplex Trading sold 771 Oramed Pharmaceuticals shares in Q1 2026, an estimated $2.62K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8517 holding.
  • Simplex Trading first reported a position in Oramed Pharmaceuticals in Q4 2014 and has held it in 21 quarters since.
  • Simplex Trading's Oramed Pharmaceuticals position peaked at $462K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.